TipRanks
Advertisement
Advertisement
Fresenius SE Earnings Call Signals Confident Upswing
PremiumCompany AnnouncementsFresenius SE Earnings Call Signals Confident Upswing
2M ago
Fresenius announces FDA approval of rituximab biosimilar
Premium
The Fly
Fresenius announces FDA approval of rituximab biosimilar
2M ago
Fresenius announces FDA, EMA acceptance of vedolizumab biosimilar for review
Premium
The Fly
Fresenius announces FDA, EMA acceptance of vedolizumab biosimilar for review
2M ago
Fresenius SE price target raised to EUR 56.60 from EUR 53.60 at JPMorgan
PremiumThe FlyFresenius SE price target raised to EUR 56.60 from EUR 53.60 at JPMorgan
7M ago
Fresenius SE price target raised to EUR 57 from EUR 56 at Deutsche Bank
Premium
The Fly
Fresenius SE price target raised to EUR 57 from EUR 56 at Deutsche Bank
7M ago
Fresenius SE Earnings Call Highlights Growth Momentum
Premium
Company Announcements
Fresenius SE Earnings Call Highlights Growth Momentum
7M ago
Fresenius SE price target raised to EUR 57 from EUR 56 at Morgan Stanley
PremiumThe FlyFresenius SE price target raised to EUR 57 from EUR 56 at Morgan Stanley
10M ago
Fresenius SE price target raised to EUR 56 from EUR 53 at Deutsche Bank
Premium
The Fly
Fresenius SE price target raised to EUR 56 from EUR 53 at Deutsche Bank
11M ago
Fresenius SE Earnings Call Highlights Strong Growth
Premium
Company Announcements
Fresenius SE Earnings Call Highlights Strong Growth
11M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―